Shikonin analogue (SA) 93/637 induces apoptosis by activation of caspase-3 in U937 cells.

Beta,beta-dimethyl acryl shikonin is an extract from the root of plant Arnebia nobilis which has been shown to possess anti-cancer activity. However, its toxicity limited further development of shikonin as a therapeutic agent. Subsequently, several analogues of beta,beta-dimethyl acryl shikonin were synthesized. One of these analogues, shikonin 93/637 was found to be significantly less toxic compared to shikonin. This study is aimed to determine the cell cycle associated differences in the susceptibility of U937 cells to apoptosis induced by shikonin analogue 93/637 (SA). Lower concentrations of SA (approximately 100 nM) showed no significant changes in cell growth. However, higher concentrations (approximately 500 nM) resulted in growth inhibition of U937 cells after 48 h of treatment with SA as measured by MTT assay. Flow cytometric analysis showed that SA treatment resulted in blocking of cell cycle progression in G1 phase. Decreased expression of Cyclin D, CDK 4 and PCNA was observed with SA treatment corroborating the G1 block. DNA gel electrophoresis showed an oligonucleotide ladder pattern, a distinct characteristic of DNA fragmentation associated with programmed cell death. Ribonuclease protection assay revealed inhibition of bcl2 expression at transcriptional level. SA treatment also resulted in induction of caspase-3 activity. The results suggest the involvement of bcl2 and Caspase-3 in SA induced apoptosis of human U937 cells.

[1]  B. Aggarwal,et al.  Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells. , 2007, Molecular cancer therapeutics.

[2]  Yi Chen,et al.  SH‐7, a new synthesized shikonin derivative, exerting its potent antitumor activities as a topoisomerase inhibitor , 2006, International journal of cancer.

[3]  A. Martelli,et al.  Intranuclear 3'-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis? , 2006, Cellular signalling.

[4]  John Mohan,et al.  Caspase-2 Triggers Bax-Bak-dependent and -independent Cell Death in Colon Cancer Cells Treated with Resveratrol* , 2006, Journal of Biological Chemistry.

[5]  D. Leitman,et al.  Tumor necrosis factor-alpha down-regulates human Cu/Zn superoxide dismutase 1 promoter via JNK/AP-1 signaling pathway. , 2006, Free radical biology & medicine.

[6]  Y. Yoo,et al.  Bcl-2 attenuates anticancer agents-induced apoptosis by sustained activation of Akt/protein kinase B in U937 cells , 2005, Apoptosis.

[7]  M. Trescol-Biémont,et al.  Regulation of A1/Bfl-1 expression in peripheral splenic B cells. , 2004, Biochimie.

[8]  M. Compton.  A biochemical hallmark of apoptosis: Internucleosomal degradation of the genome , 1992, Cancer and Metastasis Reviews.

[9]  H. Mani,et al.  Enhancement of Wound Healing by Shikonin Analogue 93/637 in Normal and Impaired Healing , 2003, Skin Pharmacology and Physiology.

[10]  Wan-Jr Syu,et al.  Antimicrobial activities of naphthazarins from Arnebia euchroma. , 2002, Journal of natural products.

[11]  J. Oppenheim,et al.  Shikonin, a component of antiinflammatory Chinese herbal medicine, selectively blocks chemokine binding to CC chemokine receptor-1. , 2001, International immunopharmacology.

[12]  Shefali,et al.  Inhibition of growth and regulation of IGFs and VEGF in human prostate cancer cell lines by shikonin analogue 93/637 (SA). , 2000, Anticancer research.

[13]  S. Hashimoto,et al.  beta-hydroxyisovalerylshikonin inhibits the cell growth of various cancer cell lines and induces apoptosis in leukemia HL-60 cells through a mechanism different from those of Fas and etoposide. , 1999, Journal of biochemistry.

[14]  C. Reutelingsperger,et al.  Plasma membrane alterations and cytoskeletal changes in apoptosis. , 1997, Experimental cell research.

[15]  N. Thornberry,et al.  Caspases: killer proteases. , 1997, Trends in biochemical sciences.

[16]  C. Kitanaka,et al.  Apoptosis in cancer. , 1996, Human cell.

[17]  Z. Werb,et al.  Proteolysis and the biochemistry of life-or-death decisions , 1996, The Journal of experimental medicine.

[18]  Seamus J. Martin,et al.  Protease activation during apoptosis: Death by a thousand cuts? , 1995, Cell.

[19]  K. Kohn,et al.  Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Lowe,et al.  p53-Dependent apoptosis suppresses tumor growth and progression in vivo , 1994, Cell.

[21]  D. Fisher.  Apoptosis in cancer therapy: Crossing the threshold , 1994, Cell.

[22]  S. Adachi,et al.  Variable susceptibility to apoptosis induced by calcium ionophore in hybridomas between HL-60 promyelocytic and CEM T-lymphoblastic leukemia cell lines: relationship to constitutive Mg(2+)-dependent endonuclease. , 1994, Experimental cell research.

[23]  G. Ronco,et al.  Selective induction of apoptosis in myeloid leukemic cell lines by monoacetone glucose-3 butyrate. , 1994, Biochemical and biophysical research communications.

[24]  M. Cleary,et al.  Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. , 1994, Blood.

[25]  Z. Darżynkiewicz,et al.  Different patterns of apoptosis of HL‐60 cells induced by cycloheximide and camptothecin , 1993, Journal of cellular physiology.

[26]  Y. Lazebnik,et al.  Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis , 1993, The Journal of cell biology.

[27]  R. Collier,et al.  DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis. , 1993, Experimental cell research.

[28]  K. Kohn,et al.  G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. , 1993, The Journal of biological chemistry.

[29]  G. Melino,et al.  Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells , 1993, FEBS letters.

[30]  H. Nakano,et al.  Induction of topoisomerase II-mediated DNA cleavage by the plant naphthoquinones plumbagin and shikonin , 1992, Antimicrobial Agents and Chemotherapy.

[31]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[32]  B. Mendelow,et al.  Unexpected cytokinetic effects induced by puromycin include a G2-arrest, a metaphase-mitotic-arrest, and apoptosis. , 1992, Leukemia research.

[33]  M. Colombel,et al.  Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. , 1992, Cancer research.

[34]  S. Wahl,et al.  IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. , 1992, Journal of immunology.

[35]  Suzanne Cory,et al.  bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship , 1991, Cell.

[36]  D. Kufe,et al.  Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabinofuranosylcytosine. , 1991, Cancer research.

[37]  S. Korsmeyer,et al.  Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population , 1990, Molecular and cellular biology.

[38]  S. Kuentzel,et al.  Cell-kill kinetics of several S-phase-specific drugs. , 1973, Cancer research.